OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in Radioligand Theranostics in Oncology
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Ismaheel O. Lawal, Sofiullah Abubakar, Honest Ndlovu, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 3, pp. 265-289
Closed Access | Times Cited: 11
Showing 11 citing articles:
Development and Evaluation of Novel 68Ga/177Lu-Labeled PSMA Inhibitors with Enhanced Pharmacokinetics and Tumor Imaging for Prostate Cancer
Haiyang Li, Yang Liu, Hongmei Yuan, et al.
Molecular Pharmaceutics (2025)
Closed Access
Haiyang Li, Yang Liu, Hongmei Yuan, et al.
Molecular Pharmaceutics (2025)
Closed Access
Sharpening the Blade of Precision Theranostics
Geoffrey Currie, Eric Rohren
Seminars in Nuclear Medicine (2025)
Open Access
Geoffrey Currie, Eric Rohren
Seminars in Nuclear Medicine (2025)
Open Access
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugates
Matthias Ocker, Christian Mayr, Petra Huber‐Cantonati, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Matthias Ocker, Christian Mayr, Petra Huber‐Cantonati, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?
Valerio Da Ros, Luca Filippi, Francesco Garaci
Expert Review of Anticancer Therapy (2024), pp. 1-5
Closed Access | Times Cited: 3
Valerio Da Ros, Luca Filippi, Francesco Garaci
Expert Review of Anticancer Therapy (2024), pp. 1-5
Closed Access | Times Cited: 3
Evaluation of Environmental Radiation Exposure and Algorithms for Determining the Occupational Effective Dose During 99mTc-MDP Bone Scintigraphy: A Comprehensive Analysis
Suphalak Khamruang Marshall, Awatif Hayeeabdunromae, Nadia Noomad, et al.
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11211-11211
Open Access | Times Cited: 2
Suphalak Khamruang Marshall, Awatif Hayeeabdunromae, Nadia Noomad, et al.
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11211-11211
Open Access | Times Cited: 2
Human–Artificial Intelligence Symbiotic Reporting for Theranostic Cancer Care
J. Harvey Turner
Cancer Biotherapy and Radiopharmaceuticals (2024)
Closed Access | Times Cited: 1
J. Harvey Turner
Cancer Biotherapy and Radiopharmaceuticals (2024)
Closed Access | Times Cited: 1
Application of 99mTc-FAPI-46 Imaging in a Patient With Medullary Thyroid Carcinoma
Nasrin Raeisi, Amin Saber Tanha, Somayeh Barashki, et al.
Clinical Nuclear Medicine (2024)
Closed Access | Times Cited: 1
Nasrin Raeisi, Amin Saber Tanha, Somayeh Barashki, et al.
Clinical Nuclear Medicine (2024)
Closed Access | Times Cited: 1
Prostate-Specific Membrane Antigen-Positron Emission Tomography-Guided Radiomics and Machine Learning in Prostate Carcinoma
Justine Maes, Simon Gesquière, Alex Maes, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3369-3369
Open Access
Justine Maes, Simon Gesquière, Alex Maes, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3369-3369
Open Access
Theranostic strategies in sarcoma: preliminary clinical evidence
Luca Filippi, Cristina Ferrari, Giuseppe Rubini
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1119-1127
Closed Access
Luca Filippi, Cristina Ferrari, Giuseppe Rubini
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 11, pp. 1119-1127
Closed Access
Radionuclide treatments of cancer: molecular mechanisms, biological responses, histopathological changes, and role of PET imaging
İsmet Sarikaya
Nuclear Medicine Communications (2024)
Closed Access
İsmet Sarikaya
Nuclear Medicine Communications (2024)
Closed Access
Preclinical evaluation of 64Cu/177Lu-labelled anti-CD30 monoclonal antibody for theranostics in CD30-positive lymphoma
Xu Yang, Jun Liu, Cuicui Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access
Xu Yang, Jun Liu, Cuicui Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access
